 | Up a level |
Zhang, Min; Guo, Rui; Wang, Hanzhong; Shi, Kuangyu; Weber, Wolfgang A; Li, Biao (2024). Sino-German symposium on total-body PET/CT in theranostics. European journal of nuclear medicine and molecular imaging, 51(11), pp. 3157-3158. Springer 10.1007/s00259-024-06786-8
Bittner, Martin-Immanuel; Wiedenmann, Nicole; Bucher, Sabine; Hentschel, Michael; Mix, Michael; Rücker, Gerta; Weber, Wolfgang A; Meyer, Philipp T; Werner, Martin; Grosu, Anca-Ligia; Kayser, Gian (2016). Analysis of relation between hypoxia PET imaging and tissue-based biomarkers during head and neck radiochemotherapy. Acta oncologica, 55(11), pp. 1299-1304. Acta Oncologica 10.1080/0284186X.2016.1219046
Wiedenmann, Nicole E; Bucher, Sabine; Hentschel, Michael; Mix, Michael; Vach, Werner; Bittner, Martin-Immanuel; Nestle, Ursula; Pfeiffer, Jens; Weber, Wolfgang A; Grosu, Anca L (2015). Serial [18F]-fluoromisonidazole PET during radiochemotherapy for locally advanced head and neck cancer and its correlation with outcome. Radiotherapy and oncology, 117(1), pp. 113-117. Elsevier 10.1016/j.radonc.2015.09.015
Wild, Damian; Fani, Melpomeni; Fischer, Richard; Del Pozzo, Luigi; Kaul, Felix; Krebs, Simone; Fischer, Richard; Rivier, Jean E F; Reubi, Jean-Claude; Maecke, Helmut R; Weber, Wolfgang A (2014). Comparison of Somatostatin Receptor Agonist and Antagonist for Peptide Receptor Radionuclide Therapy: A Pilot Study. Journal of nuclear medicine, 55(8), pp. 1248-1252. Society of Nuclear Medicine 10.2967/jnumed.114.138834
Wieser, Gesche; Mansi, Rosalba; Grosu, Anca L; Schultze-Seemann, Wolfgang; Dumont-Walter, Rebecca A; Meyer, Philipp T; Maecke, Helmut R; Reubi, Jean-Claude; Weber, Wolfgang A (2014). Positron emission tomography (PET) imaging of prostate cancer with a gastrin releasing peptide receptor antagonist - from mice to men. Theranostics, 4(4), pp. 412-419. Ivyspring International 10.7150/thno.7324
Fani, Melpomeni; Braun, Friederike; Waser, Beatrice; Beetschen, Karin; Cescato, Renzo; Erchegyi, Judit; Rivier, Jean E; Weber, Wolfgang A; Maecke, Helmut R; Reubi, Jean-Claude (2012). Unexpected sensitivity of sst2 antagonists to N-terminal radiometal modifications. Journal of nuclear medicine, 53(9), pp. 1481-9. New York, N.Y.: Society of Nuclear Medicine 10.2967/jnumed.112.102764
Walter, Martin A; Benz, Matthias R; Hildebrandt, Isabel J; Laing, Rachel E; Hartung, Verena; Damoiseaux, Robert D; Bockisch, Andreas; Phelps, Michael E; Czernin, Johannes; Weber, Wolfgang A (2011). Metabolic imaging allows early prediction of response to vandetanib. Journal of nuclear medicine, 52(2), pp. 231-40. New York, N.Y.: Society of Nuclear Medicine 10.2967/jnumed.110.081745
Wild, Damian; Christ, Emanuel; Caplin, Martyn E; Kurzawinski, Tom R; Forrer, Flavio; Brändle, Michael; Seufert, Jochen; Weber, Wolfgang A; Bomanji, Jamshed; Perren, Aurel; Ell, Peter J; Reubi, Jean Claude (2011). Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas. Journal of nuclear medicine, 52(7), pp. 1073-8. New York, N.Y.: Society of Nuclear Medicine 10.2967/jnumed.110.085142
Wild, Damian; Fani, Melpomeni; Behe, Martin; Brink, Ingo; Rivier, Jean E F; Reubi, Jean-Claude; Maecke, Helmut R; Weber, Wolfgang A (2011). First clinical evidence that imaging with somatostatin receptor antagonists is feasible. Journal of nuclear medicine, 52(9), pp. 1412-7. New York, N.Y.: Society of Nuclear Medicine 10.2967/jnumed.111.088922
Fani, Melpomeni; Del Pozzo, Luigi; Abiraj, Keelara; Mansi, Rosalba; Tamma, Maria Luisa; Cescato, Renzo; Waser, Beatrice; Weber, Wolfgang A; Reubi, Jean-Claude; Maecke, Helmut R (2011). PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference. Journal of nuclear medicine, 52(7), pp. 1110-8. New York, N.Y.: Society of Nuclear Medicine 10.2967/jnumed.111.087999
Walter, Martin A; Hildebrandt, Isabel J; Hacke, Katrin; Kesner, Adam L; Kelly, Owen; Lawson, Gregory W; Phelps, Michael E; Czernin, Johannes; Weber, Wolfgang A; Schiestl, Robert H (2010). Small-animal PET/CT for monitoring the development and response to chemotherapy of thymic lymphoma in Trp53-/- mice. Journal of nuclear medicine, 51(8), pp. 1285-92. New York, N.Y.: Society of Nuclear Medicine 10.2967/jnumed.109.073585
